Tilray Has More Cash Than Debt and 71% Growth in Europe. Is This Cannabis Stock a Buy?

Source The Motley Fool

Key Points

  • Tilray started out as a pure-play cannabis company.

  • Today, Tilray sells more alcohol than cannabis, as it has transformed into a diversified consumer staples company.

  • Tilray's financial position is strong, but it still isn't sustainably profitable.

  • 10 stocks we like better than Tilray Brands ›

For more aggressive growth investors, Tilray Brands (NASDAQ:TLRY) appears to be moving in a positive direction as a business. It may be worth buying if you have a long time horizon. However, more conservative investors will probably want to remain on the sidelines because the company still hasn't achieved one important goal: sustainable profitability. Here's why this financially strong cannabis seller is worth buying for some investors, but not for others.

Tilray Brands isn't the same company it once was

When Tilray first went public, its goal was to take advantage of the increasing legal access to cannabis. There was significant excitement in the market around the marijuana sector at the time, and the stock rose sharply alongside the rest of the sector. But the reality didn't live up to Wall Street's expectations. Competition was intense, the legalization trend was slow, and illicit marijuana sales remained robust. Tilray and the rest of the sector fell sharply.

Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »

Gloved worker holding a large black tub filled with harvested cannabis buds in an indoor growing facility.

Image source: Getty Images.

Tilray decided to move in a different direction. The goal now is to be a "global lifestyle and consumer packaged goods company leading at the nexus of the beverage, cannabis, and wellness industries." Effectively, the company is looking to operate more like a consumer staples company than a pure-play cannabis business. The biggest shift was the acquisition of alcoholic beverage brands.

In the first quarter of fiscal 2027, revenues from Tilray's alcoholic beverages stood at $101.5 million, while its cannabis revenues totaled $56.1 million. You could easily argue that Tilray is now more of an alcohol company than a marijuana company. However, the bigger story is the diversification that the company has created. That should attract growth investors who want exposure to cannabis, but who don't want to own a pure-play cannabis company.

The opportunity for pot is still attractive

The truth is, marijuana is a growing industry. The problem is that companies have had a hard time translating that growth into profits. Tilray is looking to resolve that problem by diversifying into new areas that have a more stable history, notably craft brewing. That creates a foundation on which it can continue to build its marijuana operations.

That foundation, meanwhile, is increasingly strong. Notably, it ended the first fiscal quarter of 2027 with a net cash position. That requires a little parsing, because it means the company's cash balance of roughly $215 million exceeds its long-term debt of $118 million. That's not quite as good as a debt-free balance sheet, but Tilray has a very strong financial position right at the moment.

Meanwhile, the company's growth in Europe has been a strong point, further adding to its diversification. In the first quarter, European revenues increased by 71%. From a high-level perspective, Tilray is a much stronger business today than it was not that long ago. If you are a growth investor with a long-term focus, you may want to take a closer look. It could be a good way to add marijuana exposure without having to own a pure-play.

The one problem that investors can't ignore is profits

While there is a lot to like about Tilray and the direction the business is moving, there's one important issue that remains unresolved. Tilray continues to bleed red ink on the bottom line. That single fact should probably keep more conservative investors on the sidelines. The direction the business is heading looks good, but until there are sustainable profits, an investment here remains a risky one. Buying it requires believing that Tilray's consumer-staples shift will eventually lead to a profitable and growing business. Only a more aggressive growth investor will likely be willing to make that bet.

Should you buy stock in Tilray Brands right now?

Before you buy stock in Tilray Brands, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tilray Brands wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $322,605!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $927,581!*

Now, it’s worth noting Stock Advisor’s total average return is 790% — a market-crushing outperformance compared to 202% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 19, 2026.

Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Anthropic is six times oversubscribed at $1.4 trillion while Nvidia is down 32% — the AI trade has two pricesAnthropic lists on Nasdaq as ANT on Thursday at $70 ~ $78 a share, raising up to $64.4 billion at a target valuation near $1.4 trillion, and the book is reportedly six times covered. In the same six weeks, Nvidia has fallen 32% and the QQQ is 10.9% below its October peak. Private capital and public markets are marking the same AI complex at two very different prices. This piece separates the two books: what the S-1 shows, who is anchoring the $26 billion private placement, and what Thursday's debut would have to do to change the public tape.
Author  Irene Q.
Nov 16, Mon
Anthropic lists on Nasdaq as ANT on Thursday at $70 ~ $78 a share, raising up to $64.4 billion at a target valuation near $1.4 trillion, and the book is reportedly six times covered. In the same six weeks, Nvidia has fallen 32% and the QQQ is 10.9% below its October peak. Private capital and public markets are marking the same AI complex at two very different prices. This piece separates the two books: what the S-1 shows, who is anchoring the $26 billion private placement, and what Thursday's debut would have to do to change the public tape.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 17, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
Author  Mitrade
Nov 17, Tue
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 18, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 18, 2026. Read on for the details.
Author  Mitrade
Nov 18, Wed
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 18, 2026. Read on for the details.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 19, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 19, 2026. Read on for the details.
Author  Mitrade
23 hours ago
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 19, 2026. Read on for the details.
placeholder
Gold Price Forecast: XAU/USD regains ground below $3,700, outlook remains fragileGold price (XAU/USD) attracts some bids after hitting a fresh yearly low at $3,693.50 on Thursday. In the European trade, the Gold price is 0.42% higher to near $3,740.
Author  FXStreet
18 hours ago
Gold price (XAU/USD) attracts some bids after hitting a fresh yearly low at $3,693.50 on Thursday. In the European trade, the Gold price is 0.42% higher to near $3,740.
goTop
quote